Search clinical trials for: Isocitrate Dehydrogenase Mutation
Total 3448 results
-
Robert Bok, MD, PhDNational Cancer Institute (NCI)RecruitingAdult Gliomas, MixedUnited States
-
National Cancer Institute (NCI)RecruitingCancer | Brain TumorUnited States
-
HutchmedRecruitingIsocitrate Dehydrogenase Gene MutationSpain, United States
-
University of California, San FranciscoBeiGene USA, Inc.; Pacific Pediatric Neuro-Oncology ConsortiumRecruitingGlioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent WHO Grade III Glioma | WHO Grade III Glioma | IDH2 Gene Mutation | IDH1 Gene Mutation | Low Grade Glioma | Recurrent WHO Grade II Glioma | WHO Grade II GliomaUnited States
-
University of MiamiRecruitingGlioma | Brain Tumor | Malignant Glioma | Primary Brain Tumor | Malignant Primary Brain TumorUnited States
-
CelgeneCompletedLeukemia, Myeloid | Isocitrate DehydrogenaseUnited States, Canada, China, Czechia, France, Germany, Italy, United Kingdom, Australia, Austria, Brazil, Denmark, Korea, Republic of, Russian Federation, Spain, Taiwan, Turkey, Belgium
-
HutchmedActive, not recruitingIsocitrate Dehydrogenase Gene MutationUnited States, Spain
-
CelgeneAgios Pharmaceuticals, Inc.CompletedHematologic NeoplasmsUnited States, France
-
CelgeneActive, not recruitingLeukemia, Myeloid, AcuteUnited States, France, Italy, Korea, Republic of, Spain, United Kingdom, Australia, Canada, Germany, Netherlands, Portugal, Switzerland, Belgium, Sweden
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Chronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasms (MPNs)United States, Spain, Korea, Republic of, France, Taiwan, Australia, Belgium, Singapore, Israel, Canada, Germany, Finland
-
Calithera Biosciences, IncCompletedRenal Cell Carcinoma | Non Small Cell Lung Cancer | Mesothelioma | Solid Tumors | Triple-Negative Breast Cancer | Fumarate Hydratase (FH)-Deficient Tumors | Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST) | Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal... and other conditionsUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedGlioma | Cholangiocarcinoma | ChondrosarcomaNetherlands
-
NYU Langone HealthNovartisWithdrawn
-
Orbus Therapeutics, Inc.RecruitingGlioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, IDH-wildtype | Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeUnited States
-
Debiopharm International SARecruitingAstrocytoma, Grade III | Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeSpain, United States, Switzerland
-
Institut National de la Santé Et de la Recherche...Not yet recruiting
-
Juan M Garcia-GomezHospital Universitario 12 de Octubre; Hospital Clínico Universitario de ValenciaRecruitingGlioblastoma | Glioblastoma Multiforme | High Grade Glioma | Astrocytoma, Grade IV | Glioblastoma, IDH-mutant | Glioblastoma, IDH-wildtype | Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype | Glioblastoma IDH (Isocitrate Dehydrogenase) MutantSpain
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruiting
-
University of ChicagoRecruitingBreast Cancer | Head and Neck Cancer | Gastrointestinal Cancer | Dihydropyrimidine Dehydrogenase Deficiency | UGT1A1 Gene MutationUnited States
-
Global Coalition for Adaptive ResearchBayer; Kazia Therapeutics Limited; Biohaven Pharmaceuticals, Inc.; Kintara Therapeutics... and other collaboratorsRecruitingGlioblastomaUnited States, France, Germany, Canada, Australia, Switzerland
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditionsUnited States, Australia
-
RTI InternationalEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsEnrolling by invitationPrimary Hyperoxaluria Type 3 | Diabetes Mellitus | Hemophilia A | Hemophilia B | Hereditary Fructose Intolerance | Cystic Fibrosis | Factor VII Deficiency | Phenylketonurias | Sickle Cell Disease | Dravet Syndrome | Duchenne Muscular Dystrophy | Prader-Willi Syndrome | Fragile X Syndrome | Chronic Granulomatous Disease and other conditionsUnited States
-
Incyte CorporationActive, not recruitingGlioblastoma | Adult-type Diffuse GliomasUnited States, Spain, Italy, United Kingdom, Germany, Japan, France, Netherlands, Denmark
-
Philogen S.p.A.Completed
-
Samus Therapeutics, Inc.TerminatedRecurrent Glioblastoma Multiforme (GBM) | Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma | Grade 3 or 4 Astrocytoma | Glioblastoma SurgeryUnited States
-
NYU Langone HealthEMD SeronoCompleted
-
ES Therapeutics Australia Pty LtdWithdrawn
-
Massachusetts General HospitalBristol-Myers Squibb; TargetCancer FoundationCompletedCholangiocarcinomaUnited States
-
University of PittsburghHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedMedium-chain Acyl-CoA Dehydrogenase (MCAD) DeficiencyUnited States
-
Société Française de CardiologieCompletedAltitude Intolerance | High-Altitude IllnessFrance
-
National Taiwan University HospitalUnknown
-
Quanta TherapeuticsNot yet recruitingAdvanced Solid Tumor
-
Novartis PharmaceuticalsNot yet recruitingLeukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Centre Leon BerardNot yet recruitingOral Squamous Cell CarcinomasFrance
-
Jacobio Pharmaceuticals Co., Ltd.Not yet recruitingAdvanced Non-squamous Non-small-cell Lung Cancer | Metastatic Non-squamous Non Small Cell Lung Cancer
-
AstraZenecaNot yet recruitingMetastatic Breast CancerBrazil
-
AstraZenecaDaiichi SankyoNot yet recruiting
-
M.D. Anderson Cancer CenterNot yet recruitingMetastatic Colorectal Cancer | KRAS G12C MutationsUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingEndometrial Carcinoma | Recurrent or Metastatic | TP53 MutationChina
-
Assistance Publique - Hôpitaux de ParisCentre Leon Berard; Institut National de la Santé Et de la Recherche Médicale... and other collaboratorsNot yet recruitingEnvironmental Exposure | SDH Gene Mutation | SDH-Related Familial Paraganglioma | SDHx-Related SyndromesFrance
-
Azienda Ospedaliero-Universitaria di ModenaRecruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingEarly-stage Triple-negative Breast Cancer With BRCA1/2 MutationsChina
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Radboud University Medical CenterNot yet recruitingPeritoneal Carcinoma | Ovarian Carcinoma | Serous Tubal Intraepithelial Carcinoma | BRCA Mutation
-
Pauls Stradins Clinical University HospitalRecruiting
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
Tyligand Bioscience (Shanghai) LimitedRecruitingMalignant NeoplasmUnited States
-
Jacobio Pharmaceuticals Co., Ltd.Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingAdvanced KRAS G12D Mutant Solid TumorsChina